Reduction in CD45+CD26- cells is a new pathway to be investigated in the early diagnosis of RA since it is a very complex population that includes central memory T cells (Tcm), regulatory T cells (Tregs) and others [20]. The gene discussed is PTPRC; the disease is rheumatoid arthritis.